Kevin M Jaeger

Title: Inventor Kevin M. Jaeger: Pioneering Medical Device Innovations

Introduction

Kevin M. Jaeger, based in Pleasanton, California, is a notable inventor in the field of medical devices, holding two patents that reflect his innovative contributions. His work primarily focuses on devices that enhance medical procedures and outcomes, particularly in the realm of vascular occlusion.

Latest Patents

Kevin's latest patents include a "Vaso-occlusive device comprising complex-shape proximal portion and smaller diameter distal portion," which is designed to occlude spaces within the body. This device features a proximal portion with an intricate three-dimensional shape and a distal portion that has a reduced diameter, allowing for precise placement in desired sites within the body to effectively block blood flow.

Another significant patent is the "Flexible embolic device delivery system," which presents an advanced delivery apparatus characterized by exceptional flexibility at the distal end where the embolic assembly attaches. This innovation enhances the ability to deliver embolic assemblies to target sites within a patient's body, improving procedure efficacy and patient outcomes.

Career Highlights

Kevin M. Jaeger's career includes valuable experiences at Stryker Corporation and Stryker European Holdings I LLC, where he contributed to the development of impactful medical devices that advance healthcare technology.

Collaborations

Throughout his career, Kevin has collaborated with esteemed colleagues such as Clifford Teoh and Stephen Christopher Porter. These partnerships have further enriched his innovative journey and have played a significant role in the successful development of his patented technologies.

Conclusion

Kevin M. Jaeger exemplifies the spirit of innovation in the medical device sector. His patented inventions underscore his commitment to enhancing medical procedures through technology, making significant contributions that benefit both healthcare professionals and patients alike.